• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Foothill Regional Medical Center Receives 2026 Patient Safety Excellence Award™ from Healthgrades

    3/11/26 8:00:00 AM ET
    $ASTH
    Professional Services
    Consumer Discretionary
    Get the next $ASTH alert in real time by email

    Recognition places Foothill Regional among the top 5% in the nation for patient safety

    TUSTIN, Calif., March 10, 2026 /PRNewswire/ -- Foothill Regional Medical Center, part of Astrana Health, Inc. (NASDAQ:ASTH), has been recognized as a 2026 Patient Safety Excellence Award™ recipient by Healthgrades, the nation's leading resource Americans use when searching for a hospital or doctor. Foothill Regional has received the Patient Safety Excellence Award™ four consecutive years (2023-2026).

    Foothill Regional Medical Center (part of Astrana Health) logo

    In addition to this patient safety recognition, Foothill Regional has earned several distinguished 2026 Healthgrades awards. These include being named one of Healthgrades America's 100 Best Hospitals for Joint Replacement in 2026, as well as a recipient of the Healthgrades Joint Replacement Excellence Award for two consecutive years (2025-2026). The hospital was also named among the top 10% in the nation for Joint Replacement for two years in a row (2025-2026) and recognized as a Five-Star Recipient for Total Knee Replacement for two consecutive years (2025-2026) and a Five‑Star Recipient for Hip Fracture Treatment for eight consecutive years (2019-2026). Foothill Regional additionally received Five-Star recognition for Treatment of Sepsis for three years in a row (2024-2026). Together, these achievements underscore the hospital's ongoing commitment to delivering compassionate, individualized care at every stage of the patient's journey.

    "This recognition reflects our unwavering commitment to patient safety and clinical excellence," said Araceli Lonergan, CEO of Foothill Regional Medical Center. "Our team's dedication to delivering high-quality, compassionate care is at the heart of everything we do."

    Foothill Regional's achievements are based on what matters most: patient outcomes. To determine the top-performing hospitals for patient safety, Healthgrades evaluated risk-adjusted complication and mortality rates for 4,500 hospitals nationwide across 13 Patient Safety Indicators (PSIs). Healthgrades' analysis revealed significant performance gaps between the nation's highest- and lowest-achieving facilities, making it increasingly important for consumers to seek care at a hospital with top safety ratings.

    Where you're treated matters, which is why Healthgrades is committed to providing the most scientifically accurate information about doctors and hospitals, with data insights not available anywhere else. To learn more, visit healthgrades.com.

    About Foothill Regional Medical Center

    Foothill Regional Medical Center is a general acute care hospital with 177 beds, including 42 pediatric subacute beds. Services include general and specialized surgery and robotics, orthopedics and spine program, nationally accredited weight-loss surgery program, paramedic-receiving emergency department, as well as an expanded range of quality medical programs and services. The hospital is centrally located in Orange County. As of July 2025, Foothill Regional is part of Astrana Health. To learn more, visit FoothillRegionalMedicalCenter.com or call (714) 619-7700.

    About Astrana Health, Inc.

    Astrana Health is a physician-centric, AI-powered healthcare company committed to delivering high-quality, patient-centered care. Built from the physician's perspective, Astrana combines its scalable care delivery infrastructure, proprietary technology platform, and aligned provider networks to enable proactive, preventive care at scale - improving patient outcomes, enhancing patient experiences, supporting provider well-being, and driving greater value across the healthcare system.

    Today, Astrana supports more than 20,000 providers and over 1.6 million patients in value-based care arrangements through its affiliated provider networks, management services organization, and integrated care delivery clinics spanning primary, specialty, and ancillary care. Together, Astrana is building the healthcare system we all deserve - one that delivers better care, better experiences, and better outcomes for all. For more information, visit www.astranahealth.com.

    About Healthgrades

    Healthgrades is dedicated to empowering stronger and more meaningful connections between patients and their healthcare providers. As the #1 platform for finding a doctor and a leader in healthcare transparency, Healthgrades helps millions of consumers each month find and schedule appointments with their healthcare professional of choice and prepare for their appointments with best-in-class, treatment-focused content.

    Astrana Health (PRNewsfoto/Apollo Medical Holdings, Inc.)

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/foothill-regional-medical-center-receives-2026-patient-safety-excellence-award-from-healthgrades-302710362.html

    SOURCE Astrana Health, Inc.

    Get the next $ASTH alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ASTH

    DatePrice TargetRatingAnalyst
    12/12/2025$28.00Buy
    Needham
    4/1/2025$36.00Equal Weight
    Barclays
    10/14/2024$66.00Buy
    TD Cowen
    10/11/2024Sector Weight
    KeyBanc Capital Markets
    7/11/2024$44.00 → $50.00Hold → Buy
    Truist
    5/30/2024$54.00Outperform
    Robert W. Baird
    More analyst ratings

    $ASTH
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by Astrana Health Inc.

    SCHEDULE 13G/A - Astrana Health, Inc. (0001083446) (Subject)

    3/26/26 4:07:13 PM ET
    $ASTH
    Professional Services
    Consumer Discretionary

    SEC Form 10-K filed by Astrana Health Inc.

    10-K - Astrana Health, Inc. (0001083446) (Filer)

    3/12/26 8:11:04 AM ET
    $ASTH
    Professional Services
    Consumer Discretionary

    Astrana Health Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Astrana Health, Inc. (0001083446) (Filer)

    3/4/26 7:30:49 AM ET
    $ASTH
    Professional Services
    Consumer Discretionary

    $ASTH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Needham initiated coverage on Astrana Health with a new price target

    Needham initiated coverage of Astrana Health with a rating of Buy and set a new price target of $28.00

    12/12/25 8:48:58 AM ET
    $ASTH
    Professional Services
    Consumer Discretionary

    Barclays initiated coverage on Astrana Health with a new price target

    Barclays initiated coverage of Astrana Health with a rating of Equal Weight and set a new price target of $36.00

    4/1/25 7:41:49 AM ET
    $ASTH
    Professional Services
    Consumer Discretionary

    TD Cowen initiated coverage on Astrana Health with a new price target

    TD Cowen initiated coverage of Astrana Health with a rating of Buy and set a new price target of $66.00

    10/14/24 7:24:49 AM ET
    $ASTH
    Professional Services
    Consumer Discretionary

    $ASTH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Lam Thomas S. covered exercise/tax liability with 9,266 shares, decreasing direct ownership by 2% to 423,990 units (SEC Form 4)

    4 - Astrana Health, Inc. (0001083446) (Issuer)

    3/9/26 4:16:36 PM ET
    $ASTH
    Professional Services
    Consumer Discretionary

    Chief Medical Officer Kumar Dinesh M. covered exercise/tax liability with 1,697 shares, decreasing direct ownership by 0.84% to 200,335 units (SEC Form 4)

    4 - Astrana Health, Inc. (0001083446) (Issuer)

    3/9/26 4:16:06 PM ET
    $ASTH
    Professional Services
    Consumer Discretionary

    COO and CFO Basho Chandan covered exercise/tax liability with 1,240 shares, decreasing direct ownership by 0.71% to 173,727 units (SEC Form 4)

    4 - Astrana Health, Inc. (0001083446) (Issuer)

    3/9/26 4:15:24 PM ET
    $ASTH
    Professional Services
    Consumer Discretionary

    $ASTH
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Foothill Regional Medical Center Receives 2026 Patient Safety Excellence Award™ from Healthgrades

    Recognition places Foothill Regional among the top 5% in the nation for patient safety TUSTIN, Calif., March 10, 2026 /PRNewswire/ -- Foothill Regional Medical Center, part of Astrana Health, Inc. (NASDAQ:ASTH), has been recognized as a 2026 Patient Safety Excellence Award™ recipient by Healthgrades, the nation's leading resource Americans use when searching for a hospital or doctor. Foothill Regional has received the Patient Safety Excellence Award™ four consecutive years (2023-2026). In addition to this patient safety recognition, Foothill Regional has earned several distingui

    3/11/26 8:00:00 AM ET
    $ASTH
    Professional Services
    Consumer Discretionary

    Astrana Health, Inc. to Participate in Upcoming Investor Conferences

    ALHAMBRA, Calif., March 3, 2026 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:ASTH), a physician-centric, technology-enabled healthcare company empowering providers to deliver accessible, high-quality, and high-value care to all, today announced that leadership is participating in the following upcoming investor conferences: The TD Cowen 45th Annual Health Care Conference, being held in Boston on Wednesday, March 4, 2026, including a fireside chat at 9:10am ET.The Jefferies Value-Based Healthca

    3/3/26 5:00:00 PM ET
    $ASTH
    Professional Services
    Consumer Discretionary

    Astrana Health, Inc. Reports Fourth Quarter and Year End 2025 Results

    Company to Host Conference Call on Monday, March 2, 2026, at 5:30 a.m. PT/8:30 a.m. ETReports total revenue for the year ended of $3,181.8 million, up 56% year-over-year, and at the higher end of guidanceReports adjusted EBITDA for the year ended of $205.4 million and free cash flow(1) of $104.5 millionALHAMBRA, Calif., March 2, 2026 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:ASTH), a leading physician-centric, technology-powered, risk-bearing healthcare management company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced its consolidated financial result

    3/2/26 7:00:00 AM ET
    $ASTH
    Professional Services
    Consumer Discretionary

    $ASTH
    Financials

    Live finance-specific insights

    View All

    Astrana Health, Inc. Reports Fourth Quarter and Year End 2025 Results

    Company to Host Conference Call on Monday, March 2, 2026, at 5:30 a.m. PT/8:30 a.m. ETReports total revenue for the year ended of $3,181.8 million, up 56% year-over-year, and at the higher end of guidanceReports adjusted EBITDA for the year ended of $205.4 million and free cash flow(1) of $104.5 millionALHAMBRA, Calif., March 2, 2026 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:ASTH), a leading physician-centric, technology-powered, risk-bearing healthcare management company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced its consolidated financial result

    3/2/26 7:00:00 AM ET
    $ASTH
    Professional Services
    Consumer Discretionary

    Astrana Health, Inc. Schedules 2025 Fourth Quarter and Year-End Financial Results Release and Conference Call

    ALHAMBRA, Calif., Jan. 26, 2026 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:ASTH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced that it will release financial results for the fourth quarter and year ended December 31, 2025, before the open of the stock market on Monday, March 2, 2026. The Company will discuss those results on a conference call at 5:30 a.m. PT/8:30 a.m. ET that same day.

    1/26/26 8:00:00 AM ET
    $ASTH
    Professional Services
    Consumer Discretionary

    Astrana Health, Inc. Reports Third Quarter 2025 Results

    Company to Host Conference Call on Thursday, November 6, 2025, at 2:30 p.m. PT/5:30 p.m. ET Reports total revenue of $956.0 million, up 100% year-over-year, and at the higher end of guidanceReports adjusted EBITDA of $68.5 million, at the higher end of guidanceCloses Prospect Health acquisition where standalone third quarter performance exceeded expectationsContinuing to control medical costs well; reiterating full-year trend expectationsUpdates full-year 2025 guidance to account for full-risk contract delays unrelated to core performanceALHAMBRA, Calif., Nov. 6, 2025 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (

    11/6/25 4:05:00 PM ET
    $ASTH
    Professional Services
    Consumer Discretionary